Flexion Therapeutics Company Profile (NASDAQ:FLXN)

Analyst Ratings

Consensus Ratings for Flexion Therapeutics (NASDAQ:FLXN) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $37.86 (132.34% upside)

Analysts' Ratings History for Flexion Therapeutics (NASDAQ:FLXN)
Show:
DateFirmActionRatingPrice TargetActions
7/21/2016Lake Street CapitalInitiated CoverageBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/19/2016BMO Capital MarketsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2016Janney Montgomery ScottReiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2016Needham & Company LLCReiterated RatingBuy$28.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Northland SecuritiesReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015MLV & Co.Initiated CoverageBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2014Summer StreetReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Flexion Therapeutics (NASDAQ:FLXN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/12/2016Q1($0.61)($0.78)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q3($0.60)($0.52)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.54)($0.58)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.56)($0.43)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/31/2015($0.46)($0.47)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2014Q314($0.55)($0.45)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014($0.52)($0.38)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2014($0.53)($0.86)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Flexion Therapeutics (NASDAQ:FLXN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.59)($0.59)($0.59)
Q3 20161($0.55)($0.55)($0.55)
Q4 20161($0.58)($0.58)($0.58)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Flexion Therapeutics (NASDAQ:FLXN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Flexion Therapeutics (NASDAQ:FLXN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/21/2016Samuel D ColellaDirectorBuy25,504$13.71$349,659.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2016Samuel D ColellaDirectorBuy6,778$13.84$93,807.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2016C Ann MerrifieldDirectorBuy1,000$13.39$13,390.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2016Samuel D ColellaDirectorBuy714,285$14.00$9,999,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Michael D ClaymanCEOBuy2,000$10.41$20,820.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Michael D ClaymanCEOBuy2,000$9.65$19,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Neil BodickInsiderBuy850$10.00$8,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Michael D ClaymanCEOBuy2,000$10.23$20,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Neil BodickInsiderBuy2,100$10.20$21,420.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Frederick W DriscollCFOBuy2,500$9.87$24,675.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Michael D ClaymanCEOBuy2,000$9.73$19,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Neil BodickInsiderBuy800$9.60$7,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Frederick W DriscollCFOBuy2,500$9.19$22,975.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Michael D ClaymanCEOBuy2,000$9.51$19,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Neil BodickInsiderBuy1,250$9.22$11,525.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2015C Ann MerrifieldDirectorBuy1,000$23.00$23,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015A/S NovoMajor ShareholderSell150,000$20.61$3,091,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Neil BodickInsiderSell4,000$25.28$101,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Neil BodickInsiderSell4,000$24.26$97,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2015Neil BodickInsiderSell4,000$23.45$93,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Neil BodickInsiderSell4,000$22.44$89,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2014A/S NovoMajor ShareholderBuy500,000$17.00$8,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014A/S NovoInsiderBuy692,308$13.00$9,000,004.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Bradley J Phd BolzonDirectorBuy307,692$13.00$3,999,996.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Sofinnova Partners SasMajor ShareholderBuy230,769$13.00$2,999,997.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Flexion Therapeutics (NASDAQ:FLXN)
DateHeadline
07/25/16 07:18 AMFlexion Therapeutics to Report Second-Quarter 2016 Financial Results on August 3, 2016 - [at noodls] - BURLINGTON, Mass., July 25, 2016 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it will host a conference call and webcast to report its second-quarter 2016 financial ...
07/24/16 08:32 AMA report released today by Lake Street about Flexion Therapeutics(NASDAQ:FLXN) raises the target price to $38
07/21/16 07:52 AMCoverage initiated on Flexion Therapeutics by Lake Street -
07/21/16 07:34 AMFlexion Therapeutics Incorporated (NASDAQ:FLXN) Shorted Shares Increased By 10.84% - Consumer Eagle
07/20/16 05:22 PMBroker Outlook For Flexion Therapeutics Inc (FLXN) - Fiscal Standard
07/17/16 08:32 AMShares Moving Down on the Week: Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Engelwood Daily
07/14/16 09:22 PMFlexion Therapeutics Incorporated (NASDAQ:FLXN) Shorted Shares Increased By 35.39% - Consumer Eagle
07/14/16 09:22 PMFlexion Therapeutics Inc Realized Volatility Hits Extreme Level - CML News
07/13/16 05:10 AMInstitutional Investors Are Buying Flexion Therapeutics Inc (NASDAQ:FLXN) - Consumer Eagle
07/12/16 07:15 AMBillionaires Are Piling Into These 3 Stocks -
07/10/16 08:31 AMWere Analysts Bearish Flexion Therapeutics Inc (NASDAQ:FLXN) This Week? - Engelwood Daily
07/10/16 08:31 AMNext Weeks Broker Price Targets For Flexion Therapeutics Inc (FLXN) - Fiscal Standard
07/08/16 04:01 PMBrokers Issue Average Price Target Of 35.51 On Flexion Therapeutics Inc (FLXN) - Fiscal Standard
07/08/16 04:01 PMFlexion Therapeutics: Insider Buying Signals Attractive Opportunity - Seeking Alpha
07/08/16 05:17 AMFlexion Therapeutics, Inc. Stock Momentum Hits Strength - CML News
07/07/16 05:07 AMTime to Buy Flexion Therapeutics Inc After Today's Huge Increase? - Engelwood Daily
07/06/16 09:50 PMShares Heading Higher in Session: Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Telanagana Press
07/06/16 04:07 PMFlexion Therapeutics Incorporated (NASDAQ:FLXN) Shorted Shares Increased 35.39% After Market Selling - Press Telegraph
07/06/16 04:06 PMBMO Capital Initiates Coverage on Flexion Therapeutics Inc to Outperform - TheFounders Daily
07/06/16 04:06 PMWhy Flexion Therapeutics Is Adding 3 New Executives to Its Ranks - 24/7 Wall St.
07/06/16 10:10 AMWhy Flexion Therapeutics Is Adding 3 New Executives to Its Ranks -
07/05/16 08:44 AMFlexion Therapeutics Inc (FLXN) Updated Price Targets - FTSE News
07/02/16 03:55 PMHow Analysts Rated Flexion Therapeutics Inc (NASDAQ:FLXN) Last Week? - Press Telegraph
07/01/16 05:28 AMRecently Issued Stock Ratings For Flexion Therapeutics Inc (FLXN) - Fiscal Standard
06/28/16 09:00 PMCheck on Share Volatility: Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Engelwood Daily
06/22/16 08:43 AMFlexion Therapeutics Inc. (FLXN) Jumps 5.57% on June 20 - Equities.com
06/20/16 10:15 AMThis Weeks Broker Views For Flexion Therapeutics Inc (FLXN) - Fiscal Standard
06/16/16 03:31 PMFLEXION THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/16/16 08:24 AMFlexion Therapeutics Inc (FLXN) Current Analyst Ratings - Fiscal Standard
06/09/16 04:05 PMMedtronic PLC (NYSE:MDT) & Flexion Therapeutics (NASDAQ:FLXN) Healthcare Stock's Buzzers - Wall Street 24
06/09/16 04:05 PMAnalyst Recommended Stock: Flexion Therapeutics, Inc. (NASDAQ:FLXN) - News Oracle
06/09/16 04:05 PMAnalyst Overview on These 2 Stocks: Flexion Therapeutics, Inc. (NASDAQ:FLXN), Telefonica Brasil S.A. (NYSE:VIV) - Beacon Chronicle
06/08/16 04:14 PMFLEXION THERAPEUTICS INC. (NASDAQ:FLXN) Financial Condition Compared to S&P 500 - CML News
06/08/16 04:14 PMWhy Flexion Therapeutics Inc (FLXN), Micron Technology, Inc. (MU) and VeriFone Systems Inc (PAY) Are Three of ... - Investorplace.com
06/08/16 06:42 AMAfter-Hours Stock Movers 06/07: (GEVO) (HHS) (PLAY) Higher; (PAY) (FLXN) (DLTH) Lower (more...)
06/07/16 04:08 PMFlexion Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewswire (press release)
06/07/16 03:18 PMFlexion Therapeutics Announces Proposed Public Offering of Common Stock - [at noodls] - BURLINGTON, Mass., June 07, 2016 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has commenced an underwritten public offering, subject to market and other conditions, ...
06/07/16 03:07 PMFLEXION THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/04/16 06:20 AM‘Sleepy’ Bedford biotech Anika wakes up investors with recent success -
06/03/16 06:20 AMFlexion Therapeutics Inc. (FLXN) is Trading Lower on Unusual Volume for June 01 - Equities.com - Flexion Therapeutics Inc. (FLXN) is Trading Lower on Unusual Volume for June 01Equities.comFlexion Therapeutics Inc. (FLXN) experienced unusually high volume on Jun. 01, as the stock lost 3.5% to a closing price of $16.83. The stock saw 576,781 shares trade hands over the course of the day on 3,440 trades. Given that the stock's average ...
06/02/16 04:15 PMFlexion Therapeutics Inc (FLXN) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Flexion Therapeutics Inc (FLXN) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Flexion Therapeutics Inc (FLXN). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...and more »
06/02/16 04:15 PMFlexion Therapeutics Inc (FLXN) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Flexion Therapeutics Inc (FLXN) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Flexion Therapeutics Inc (FLXN). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...and more »
06/02/16 12:00 PMFlexion Therapeutics, Inc. :FLXN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 -
06/01/16 04:16 PMFlexion Therapeutics, Inc. (NASDAQ:FLXN) Soared 12.30%: Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC), Pitney ... - KC Register - Flexion Therapeutics, Inc. (NASDAQ:FLXN) Soared 12.30%: Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC), Pitney ...KC RegisterOn May 26, Flexion Therapeutics, Inc. (NASDAQ:FLXN) announces that it received written responses from the U.S. Food & Drug Administration (FDA) to questions the company had submitted in advance of a pre-NDA meeting regarding Flexion's lead product ...and more »
06/01/16 06:27 AMFlexion Therapeutics Inc. (FLXN) is Trading Lower on Unusual Volume for May 30 - Equities.com - Flexion Therapeutics Inc. (FLXN) is Trading Lower on Unusual Volume for May 30Equities.comFlexion Therapeutics Inc. (FLXN) experienced unusually high volume on May. 30, as the stock lost 9.87% to a closing price of $15.53. The stock saw 1.05 million shares trade hands over the course of the day on 7,091 trades. Given that the stock's ...
06/01/16 06:27 AMFlexion Therapeutics Inc. (FLXN) Jumps 12.3% on May 31 - Equities.com - Flexion Therapeutics Inc. (FLXN) Jumps 12.3% on May 31Equities.comFlexion Therapeutics Inc. (FLXN) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 12.3% to $17.44, representing a gain of $1.91 per share. Some 815,146 shares traded hands on 5,241 trades, compared with an ...and more »
05/31/16 09:51 PMFlexion Therapeutics, Inc. (NASDAQ:FLXN) Stock Update & Estimates - Stock Tick Tock - Flexion Therapeutics, Inc. (NASDAQ:FLXN) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Flexion Therapeutics, Inc. (NASDAQ:FLXN) to post earnings of $-0.79 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be ...and more »
05/31/16 10:14 AMHealthcare Stocks to watch: Merck & Company, Inc. (NYSE:MRK) , Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Is stories - Is storiesHealthcare Stocks to watch: Merck & Company, Inc. (NYSE:MRK) , Flexion Therapeutics, Inc. (NASDAQ:FLXN)Is storiesIn most recently trading session on 5/27/2016, Flexion Therapeutics, Inc. (NASDAQ:FLXN) dropped -9.87% while traded on 1.05 million shares versus it's an average volume of 250.66 thousand shares. The company recorded the last trade with the price of ...and more »
05/31/16 10:14 AMAnalyst Overview on These Stocks: Flexion Therapeutics Inc (NASDAQ:FLXN), Shire PLC (ADR) (NASDAQ:SHPG) - Beacon Chronicle - Analyst Overview on These Stocks: Flexion Therapeutics Inc (NASDAQ:FLXN), Shire PLC (ADR) (NASDAQ:SHPG)Beacon ChronicleLast Trade: The Company closed its last session at $15.53 Friday with the loss of -9.87%. The market capitalization of the company is $301.94 million, with the average Volume of $264,719.00. The stock currently has its 52-Week High range of $29.09 and ...and more »
05/31/16 10:14 AMFlexion Therapeutics Inc (NASDAQ:FLXN) Dips After Upside Run; Discount Entry Opportunity? - Market Exclusive - Market ExclusiveFlexion Therapeutics Inc (NASDAQ:FLXN) Dips After Upside Run; Discount Entry Opportunity?Market ExclusiveFlexion Therapeutics Inc (NASDAQ:FLXN) just offered up some insight into its development pipeline prospects, and while the inference is positive, wider markets have taken a critical stance on the release. The company is down close to 10% on its Friday ...Flexion Therapeutics, Inc. (NASDAQ:FLXN) 1-Year High At $29.09Equities FocusFlexion Therapeutics, Inc. (NASDAQ:FLXN) Earns Consensus Buy RatingiStreetWireall 4 news articles »

Social

About Flexion Therapeutics

Flexion Therapeutics logoFlexion Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis and post-operative pain. The Company's portfolio of product candidates addresses the OA pain treatment spectrum, from moderate to severe pain. The Company's lead product candidate, Zilretta (also known as FX006), is a late-stage, injectable, sustained-release, intra-articular (IA) steroid for patients with moderate to severe OA pain. The Company's other product candidates include FX007, a preclinical, small-molecule tropomyosin receptor kinase A (TrkA) receptor antagonist designed to address post-operative pain, and FX005, a sustained-release p38 mitogen-activated protein (MAP), kinase inhibitor for the treatment of end-stage OA patients. The Company has not generated any revenue.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: FLXN
  • CUSIP:
Key Metrics:
  • Previous Close: $16.85
  • 50 Day Moving Average: $15.05
  • 200 Day Moving Average: $12.69
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $363.45M
  • Beta: 1.45
  • Current Year EPS Consensus Estimate: $-2.7500 EPS
  • Next Year EPS Consensus Estimate: $-2.8500 EPS
Additional Links:
Flexion Therapeutics (NASDAQ:FLXN) Chart for Monday, July, 25, 2016